Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions — but this requires an injection. Now researchers report in the journal ACS Applied Materials & Interfaces a new way to deliver the treatment topically, without a needle.
The rear part of the eye is where conditions such as proliferative diabetic retinopathy and age-related macular degeneration develop. And they involve a substance called vascular endothelial growth factor, which stimulates the growth of blood vessels. Scientists have been trying to inhibit the growth factor using gene therapy, but delivering drugs to the back of the eye currently requires an injection. Not surprisingly, few patients opt for this type of treatment. Gang Wei and colleagues wanted to find a noninvasive approach.
The researchers developed a gene delivery system with a peptide called penetratin, which has shown good permeability in the eye, and a synthetic polymer called poly(amidoamine) that has previously been used in drug delivery. Testing on rats showed that the complex, when applied as an eye drop, rapidly moved from the eye’s surface to its rear inner lining. It remained in the retina for more than eight hours — enough time for a model gene to be expressed. The findings demonstrate the method’s potential for delivering gene therapy to treat several eye diseases, the researchers say.
The Latest on: Gene therapy in a droplet
via Google News
The Latest on: Gene therapy in a droplet
- Column: For a man long afflicted with an illness made riskier by COVID-19, hope for the holidayson November 29, 2020 at 2:00 pm
Black people are the overwhelming victims of sickle cell anemia. An experimental gene therapy being tested on Evie Junior, 27, gives him reason to feel positive.
- Genscript Biotech plunges after chairman of Chinese gene and cell therapy firm is arrested on suspected smuggling offenceon November 22, 2020 at 9:57 pm
Zhang Fangliang, a co-founder of the Nanjing-based gene and cell therapy firm, has been arrested after a period under “residential surveillance,” the company said in a stock exchange filing ...
- Avrobio tracks improvements in first patient treated with Gaucher gene therapyon November 17, 2020 at 4:18 am
Avrobio has shared data on the first Gaucher disease patient to receive its gene therapy AVR-RD-02. The patient, who was stable on enzyme replacement therapy at baseline, experienced a 22% drop in a ...
- AVROBIO Announces New Positive Clinical Data and Preclinical Data, as Well as Expanded Leading Lysosomal Disorder Gene Therapy Pipelineon November 17, 2020 at 4:04 am
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced positive new data across its clinical ...
- AVROBIO Announces New Positive Clinical Data and Preclinical Data, as Well as Expanded Leading Lysosomal Disorder Gene Therapy Pipelineon November 17, 2020 at 4:03 am
Three months post-gene therapy infusion, the first Gaucher disease ... remains off both oral and eye drop cysteamine and we are thrilled to announce that a third patient has been dosed.
- Adverum ticks lower on underwhelming data from gene therapy in wet-AMDon November 16, 2020 at 12:17 pm
the patients are on a 6-week eye drop steroid regimen. Only 1 of the patients on the lower dose of the gene therapy (cohorts 2 and 3) had inflammation, however, 10 of the 15 were free of ...
- Adverum Biotechnologies Announces Positive Interim Data from Cohorts 1-4 from OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMDon November 14, 2020 at 9:54 am
Nov. 14, 2020 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced ...
- Peter H. Diamandis: Metatrends shaping the next decadeon November 12, 2020 at 2:44 pm
The price per kilowatt-hour will drop below 1 cent per kilowatt-hour ... various biotechnologies (CRISPR, Gene Therapy), genome sequencing, and artificial intelligence. If understanding how ...
- Don’t drop your diet yet, but scientists have discovered how CRISPR can burn faton October 28, 2020 at 11:05 am
A personalized therapy for metabolic conditions that are ... transforming it into an energy-burning variation using CRISPR gene-editing, and then re-implanting it into the body, according to ...
- Hero dad who walked 700 miles barefoot for poorly daughter overwhelmed with Pride of Britainon October 28, 2020 at 4:29 am
You could have heard a pin drop as Strictly Come Dancing winner ... His herculean effort has raised funds for gene therapy which will hopefully change Hasti’s life. His daughter has Cornelia ...
via Bing News